Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$2.78 USD
-0.11 (-3.81%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $2.81 +0.03 (1.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CLOV 2.78 -0.11(-3.81%)
Will CLOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
Here's Why MOH Shares Are Attracting Prudent Investors Now
Ensign Enhances Presence With 3 New Acquisitions in 2 States
Other News for CLOV
CLOV Supports Initiative for Unified Healthcare Data Ecosystem
Clover 'supports' White House, CMS' push for simplifying health data access
Novo Nordisk Stock is on Sale- A Cash Flow Giant
Clover Health Investments Corp (CLOV) Announces Key Leadership Appointment at Counterpart ...